Pivotal Therapeutics Announces Notification of Patent Allowance for U.S. Application 13584480 Related to Combination Product of VASCAZENÂ and Statin Therapy

WOODBRIDGE ON Oct. 7 2014 PRNewswire Pivotal Therapeutics Inc. OTCQXPVTTF; CSEPVO "Pivotal" or the "Company" a specialty pharmaceutical company with a focus on Omega3 therapies for cardiovascular disease and overall health announced th...